PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
12.56%
Net income growth under 50% of CRK's 46.18%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-3.78%
Negative yoy D&A while CRK is 279.23%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-355.68%
Negative yoy deferred tax while CRK stands at 2.39%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
10.87%
SBC growth while CRK is negative at -8.14%. John Neff would see competitor possibly controlling share issuance more tightly.
-116.13%
Negative yoy working capital usage while CRK is 336.68%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-88.00%
AR is negative yoy while CRK is 175.29%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
141.64%
Inventory growth well above CRK's 100.00%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
80.58%
AP growth well above CRK's 46.14%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-116.13%
Both reduce yoy usage, with CRK at -321.12%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-4.71%
Both negative yoy, with CRK at -1970.04%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-9.04%
Both yoy CFO lines are negative, with CRK at -9.68%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
29.94%
Some CapEx rise while CRK is negative at -18.43%. John Neff would see competitor possibly building capacity while we hold back expansions.
-219.25%
Negative yoy acquisition while CRK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-38.24%
Both yoy lines negative, with CRK at -124.86%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-123.86%
Both yoy lines negative, with CRK at -30.28%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
99.81%
Debt repayment above 1.5x CRK's 58.33%, indicating stronger deleveraging. David Dodd would verify if expansions are not neglected.
No Data
No Data available this quarter, please select a different quarter.
42.15%
Buyback growth below 50% of CRK's 100.00%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.